US$ 29.42
glp 1 drug market GLP-1 Agonists Size, Share, Growth Insights 2032 GLP-1 Weight-Loss Drugs Ride Health,
Description
These medications are used for chronic weight management and treating type 2 diabetes

This article explains the gastrointestinal effects of GLP-1 therapy and provides practical guidance for managing bowel changes during treatment

A comprehensive literature search was performed using electronic databases including PubMed, Scopus, and Google Scholar

Calculate it

Boland et al

With a large portfolio of products of GLP-1 drugs, Novo Nordisk is expected to capture 55% of the market share in 2029
